HIGHLIGHTS
SUMMARY
The vaccine immunogenicity was evaluated by measuring the serum IgG neutralizing Ab levels against the RBD portion of the spike_protein (anti-S), using the IgG II Quant kit (Abbott, Chicago, IL, USA), a chemiluminescent microparticle immunoassay (CIMSA) according to the manufacturer`s instructions on an Architect i2000SR/i4000SR platform. The role of other arms of the immune_response, namely cellular immunity elicited by CD4+ and CD8+ T_cells, known to be raised by vaccination, must be taken into consideration, and this point is not addressed by the study. In fact, the first subset of T_cells is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.